Advances in Hematology / 2012 / Article / Fig 1

Research Article

DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil

Figure 1

Comparison of the estimated overall survival according to the risk category with a followup of 120 months: favorable (54.9%), intermediate (39%), and unfavorable (16.7%) ( ).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.